Home > PE Ratio > WINDLAS BIOTECH

WINDLAS BIOTECH
PE (Price/Earnings) Ratio

The Current P/E Ratio of WINDLAS BIOTECH is 21.58.

Share Price ₹546.2Apr 26,2024
Market Cap ₹1,136.1 Cr
Earnings-TTM₹52.6 CrTTM-Consolidated Results
Price/Earnings21.58xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of WINDLAS BIOTECH

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of WINDLAS BIOTECH is calculated as :

Current Market Cap [ ₹1,136.1 Cr] as on Apr 26,2024

(/) Earnings [ ₹52.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 21.58x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for WINDLAS BIOTECH , the investors are currently willing to pay 21.58 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WINDLAS BIOTECH !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of WINDLAS BIOTECH over the last five years.

Historical PE (Price/Earnings) ratio chart of WINDLAS BIOTECH


PE Ratio Performance Analysis for WINDLAS BIOTECH

- WINDLAS BIOTECH 's latest p/e ratio is 21.58x.

- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.62x.

- WINDLAS BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2022 at 12.02x.

- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does WINDLAS BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
WINDLAS BIOTECH 52.6421.581,136.1
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.11360,920.0
CIPLA LTD3,744.0330.39113,794.0
DR REDDYS LABORATORIES LTD5,209.4020.02104,316.0
ZYDUS LIFESCIENCES LTD2,954.2032.2995,380.9
DIVIS LABORATORIES LTD1,382.9777.27106,860.0
MANKIND PHARMA LTD1,743.3054.4294,869.4
TORRENT PHARMACEUTICALS LTD1,494.0060.9591,057.0
LUPIN LTD1,809.7440.6973,642.4
AUROBINDO PHARMA LTD2,777.8923.8666,278.5
ABBOTT INDIA LTD1,145.5847.9854,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WINDLAS BIOTECH 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 20.02x
Max industry PE 77.27x
Median industry PE 40.11x
Average industry PE 40.87x



You may also like the below Video Courses